{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:26:58Z","timestamp":1649125618305},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1985,3,1]],"date-time":"1985-03-01T00:00:00Z","timestamp":478483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1985,3]]},"DOI":"10.1007\/bf00609679","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T01:55:48Z","timestamp":1101347748000},"page":"131-134","source":"Crossref","is-referenced-by-count":4,"title":["Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease"],"prefix":"10.1007","volume":"28","author":[{"given":"E.","family":"van der Veur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. S.","family":"ten Berge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Wouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl","key":"CR1","first-page":"681","volume":"3","author":"RI Brittain","year":"1976","unstructured":"Brittain RI, Levy GP (1976) A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor blocking drug. Br J Clin Pharmacol [Suppl] 3: 681?694","journal-title":"Br J Clin Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"453s","DOI":"10.1042\/cs059453s","volume":"59","author":"JM Cruickshank","year":"1980","unstructured":"Cruickshank JM, Neil-Dwyer G, Cameron MM, Mc Ainsh J (1980) Beta-adrenoreceptor blocking agents and the blood-brain barrier. Clin Sci 59: 453s-455s","journal-title":"Clin Sci"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.1969.03160130055016","volume":"208","author":"ED Frohlich","year":"1969","unstructured":"Frohlich ED, Larazi RC, Dustan HP (1969) Peripheral arterial insufficiency: a complication of beta adrenergic blocking therapy. J Am Med Assoc 208: 2471?2472","journal-title":"J Am Med Assoc"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/cs061429s","volume":"61","author":"I Heck","year":"1981","unstructured":"Heck I, Tr\u00fcbestein G, Stumpe KO (1981) Effects of combined ?-and ?-receptor blockade on peripheral circulation in essential hypertension. Clin Sci 61: 429?432","journal-title":"Clin Sci"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2125.1981.tb01227.x","volume":"12","author":"MA Ireland","year":"1981","unstructured":"Ireland MA, Littler WA (1981) The effects of oral acebutolol and propranolol on forearm blood flow in hypertensive patients. Br J Clin Pharmacol 12: 363?368","journal-title":"Br J Clin Pharmacol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/bmj.1.6024.1498","volume":"1","author":"AJ Marshall","year":"1976","unstructured":"Marshall AJ, Roberts CJC, Barrit DW (1976) Raynaud's phenomenon as side effect of ?-blockers in hypertension. Br Med J 1: 1498?1499","journal-title":"Br Med J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.0954-6820.1981.tb09804.x","volume":"210","author":"O Ohlsson","year":"1981","unstructured":"Ohlsson O, Lindell S-E (1981) The effects of pindolol and prazosin on hand blood flow in patients with cold extremities and on treatment with ?-blockers. Acta Med Scand 210: 217?219","journal-title":"Acta Med Scand"},{"key":"CR8","first-page":"378","volume":"10","author":"L Pater de","year":"1962","unstructured":"de Pater L, van der Berg JW, Bueno AA (1962) A very sensitive photoplethysmograph using scattered light and a photosensitive resistance. Acta Physiol Pharmacol Neerl 10: 378?390","journal-title":"Acta Physiol Pharmacol Neerl"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00003495-197407010-00006","volume":"7","author":"FO Simpson","year":"1974","unstructured":"Simpson FO (1974) ?-adrenergic receptor blocking drugs in hypertension. Drugs 7: 85?105","journal-title":"Drugs"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.1979.tb00953.x","volume":"7","author":"JA Steiner","year":"1979","unstructured":"Steiner JA, Cooper R, Gear JS, Ledingham JGG (1979) Vascular symptoms in patients with primary Renaud's phenomenon are not exacerbated by propranolol or labetalol. Br J Clin Pharmacol 7: 401?403","journal-title":"Br J Clin Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2165\/00003495-197612060-00002","volume":"12","author":"HJ Waal-Manning","year":"1976","unstructured":"Waal-Manning HJ (1976) Hypertension: which beta-blocker? Drugs 12: 412?441","journal-title":"Drugs"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00615400","volume":"20","author":"H Wesseling","year":"1981","unstructured":"Wesseling H, den Heeten A, Wouda AA (1981) Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon. Eur J Clin Pharmacol 20: 329?333","journal-title":"Eur J Clin Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.280.6218.885","volume":"280","author":"RG Wilcox","year":"1980","unstructured":"Wilcox RG (1980) Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J 280: 885?888","journal-title":"Br Med J"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.0954-6820.1977.tb15740.x","volume":"201","author":"AA Wouda","year":"1977","unstructured":"Wouda AA (1977) Raynaud's phenomenon. Acta Med Scand 201: 519?523","journal-title":"Acta Med Scand"},{"key":"CR15","first-page":"87","volume":"52","author":"FJ Zacharias","year":"1976","unstructured":"Zacharias FJ (1976) Patient acceptability of propranolol and the occurrence of side-effects. Postgrad Med J 52: 87?89","journal-title":"Postgrad Med J"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00609679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00609679\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00609679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T03:24:46Z","timestamp":1554434686000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00609679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,3]]}},"alternative-id":["BF00609679"],"URL":"https:\/\/doi.org\/10.1007\/bf00609679","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,3]]}}}